Related Experiment Video

Updated: Jun 18, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Menopausal hot flush: is it only a nuisance or also a marker of cardiovascular disease risk?

Maria Andrikoula1, Paul Hardiman, Gordana Prelevic

  • 1Department of Endocrinology, University Hospital of Ioannina, Ioannina, Greece. mandrikoula@doctors.org.uk

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|November 12, 2009
PubMed

Insights

Persistent hot flushes during menopause may indicate an increased risk for cardiovascular disease. Further research is needed to understand why some women experience hot flushes and their connection to heart health.

Area of Science:

  • Reproductive Endocrinology
  • Cardiovascular Health
  • Menopause Studies

Background:

  • Hot flushes are common menopause symptoms, but not universal.
  • The underlying reasons for experiencing hot flushes remain unclear.
  • Potential links between hot flushes and cardiovascular disease risk are being investigated.

Purpose of the Study:

  • To review current evidence linking hot flushes to cardiovascular disease.
  • To explore the significance of persistent hot flushes as a potential health marker.

Main Methods:

  • Literature review of existing research on hot flushes and cardiovascular outcomes.
  • Analysis of studies examining the duration and severity of hot flushes in relation to cardiovascular risk factors.

Main Results:

  • Evidence suggests a correlation between hot flushes and increased cardiovascular disease risk.
  • Persistent hot flushes may signify an underlying condition elevating cardiovascular risk.

Conclusions:

  • Hot flushes can be more than a menopausal symptom; they may signal underlying health issues.
  • The persistence of hot flushes warrants further investigation as a potential cardiovascular disease risk marker.

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...